MicroRNA-153-5p Promotes the Proliferation and Metastasis of Renal Cell Carcinoma Via Direct Targeting of AGO1

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2021 Jan 8

PMID 33414440

Citations 17

Authors

Zeyan Li

Shuo Zhao

Shiqin Zhu

Yidong Fan

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) have been demonstrated to affect the biological processes of cancers and showed great potential for prognostic biomarkers. In this study, we screened differentially expressed miRNAs in ccRCC based on three dimensions of metastasis, prognosis, and differential expression compared to normal tissue using bioinformatics algorithms. MiR-153-5p was identified as a candidate miRNA to promote ccRCC occurrence and progression. Clinically, we found that miR-153-5p was significantly upregulated and related to unfavorable clinical features in ccRCC. Besides, miR-153-5p served as an independent prognostic biomarker. Functionally, miR-153-5p depletion remarkably inhibited the proliferation and metastasis of ccRCC via the phosphatidylinositol 3-kinase (PI3K)/Akt signaling. Furthermore, AGO1 was proved to be a direct target of miR-153-5p. AGO1 is associated with favorable clinical features and exhibited independent prognostic value in ccRCC. Besides, we observed that AGO1 knockdown significantly promoted tumor proliferation and metastasis. Downregulation of AGO1 partly abolished the oncogenic effects of miR-153-5p knockdown. Furthermore, miR-153-5p combined with AGO1 showed more robust prognostic significance in ccRCC. In conclusion, we found that the newly identified miR-153-5p/AGO1 axis was responsible for tumor occurrence and progression via PI3K/Akt signaling, which may therefore provide promising therapeutic targets and prognostic biomarkers for patients with ccRCC.

Citing Articles

Identification of PI3K-AKT Pathway-Related Genes and Construction of Prognostic Prediction Model for ccRCC.

Hu S, Zhang X, Xin H, Guo M, Xiao Y, Chang Z Cancer Rep (Hoboken). 2024; 7(9):e70010.

PMID: 39233640 PMC: 11375326. DOI: 10.1002/cnr2.70010.

Long non-coding RNA MIMT1 promotes retinoblastoma proliferation via sponging miR-153-5p to upregulate FGF2.

Wang B, Cai R, Sun T, Yang Z, Zhang H Heliyon. 2024; 10(13):e34243.

PMID: 39091947 PMC: 11292528. DOI: 10.1016/j.heliyon.2024.e34243.

A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.

Su Q, Zhu Y, He B, Dai B, Mu W, Tian J Eur J Med Res. 2023; 28(1):545.

PMID: 38017548 PMC: 10683297. DOI: 10.1186/s40001-023-01522-8.

ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.

Wu M, Li R, Qin J, Wang Z, Guo J, Lv F J Mol Histol. 2023; 54(6):621-631.

PMID: 37776473 DOI: 10.1007/s10735-023-10149-2.

LINC01354 enhances the metastatic ability of gastric cancer cells by adjusting miR-153-5p/CADM2 expression.

Fang F, Gu Y, Gao J, An L, Kang J, Mu Q Am J Cancer Res. 2023; 13(6):2630-2643.

PMID: 37424819 PMC: 10326585.

References

Hutvagner G, Simard M . Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol. 2007; 9(1):22-32. DOI: 10.1038/nrm2321. View

Li Y, Guan B, Liu J, Zhang Z, He S, Zhan Y . MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. EBioMedicine. 2019; 44:439-451. PMC: 6604878. DOI: 10.1016/j.ebiom.2019.05.041. View

Sasaki T, Shiohama A, Minoshima S, Shimizu N . Identification of eight members of the Argonaute family in the human genome. Genomics. 2003; 82(3):323-30. DOI: 10.1016/s0888-7543(03)00129-0. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Rabien A, Ratert N, Hogner A, Erbersdobler A, Jung K, Ecke T . Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder. Int J Mol Sci. 2018; 19(6). PMC: 6032056. DOI: 10.3390/ijms19061622. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

Huang Q, Xia J, Wang L, Wang X, Ma X, Deng Q . miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol. 2018; 11(1):58. PMC: 5914051. DOI: 10.1186/s13045-018-0600-x. View

Liang H, Ge F, Xu Y, Xiao J, Zhou Z, Liu R . miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells. Angiogenesis. 2018; 21(4):849-860. PMC: 6208884. DOI: 10.1007/s10456-018-9630-9. View

Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y . Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 2014; 5:e1155. PMC: 5424105. DOI: 10.1038/cddis.2014.122. View

10.

Moch H, Cubilla A, Humphrey P, Reuter V, Ulbright T . The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016; 70(1):93-105. DOI: 10.1016/j.eururo.2016.02.029. View

11.

Lee H, Her N, Kang D, Jung S, Shin J, Lee M . Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase. Cell Death Dis. 2017; 8(3):e2693. PMC: 5386522. DOI: 10.1038/cddis.2017.116. View

12.

Chamorro-Jorganes A, Araldi E, Suarez Y . MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. Pharmacol Res. 2013; 75:15-27. PMC: 3752325. DOI: 10.1016/j.phrs.2013.04.002. View

13.

Guo H, German P, Bai S, Barnes S, Guo W, Qi X . The PI3K/AKT Pathway and Renal Cell Carcinoma. J Genet Genomics. 2015; 42(7):343-53. PMC: 4624215. DOI: 10.1016/j.jgg.2015.03.003. View

14.

Vasaikar S, Straub P, Wang J, Zhang B . LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2017; 46(D1):D956-D963. PMC: 5753188. DOI: 10.1093/nar/gkx1090. View

15.

Li H, You Q, Xu L, Sun L, Majid A, Xia X . Long Non-Coding RNA-MALAT1 Mediates Retinal Ganglion Cell Apoptosis Through the PI3K/Akt Signaling Pathway in Rats with Glaucoma. Cell Physiol Biochem. 2017; 43(5):2117-2132. DOI: 10.1159/000484231. View

16.

Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z . MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene. 2013; 33(24):3119-28. DOI: 10.1038/onc.2013.286. View

17.

Voller D, Linck L, Bruckmann A, Hauptmann J, Deutzmann R, Meister G . Argonaute Family Protein Expression in Normal Tissue and Cancer Entities. PLoS One. 2016; 11(8):e0161165. PMC: 4982624. DOI: 10.1371/journal.pone.0161165. View

18.

Ambros V . The evolution of our thinking about microRNAs. Nat Med. 2008; 14(10):1036-40. DOI: 10.1038/nm1008-1036. View

19.

Li Z, Liu J, Zhang X, Fang L, Zhang C, Zhang Z . Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis. Pathol Oncol Res. 2019; 26(3):1401-1409. DOI: 10.1007/s12253-019-00776-0. View

20.

Rupaimoole R, Slack F . MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017; 16(3):203-222. DOI: 10.1038/nrd.2016.246. View